LH/hCG-receptor expression may have a negative prognostic value in low-risk endometrial cancer.

LH/hCG-receptor expression may have a negative prognostic value in low-risk endometrial cancer.

Introduction: A 51 years-old woman was diagnosed with endometrial cancer and underwent surgical staging. Pathologic evaluation showed a 2x1 cm G2 endometrioid endometrial cancer with a 30% myometrial deep invasion (FIGO stage 1A). The patient was classified as low-risk of recurrence and no adjuvant...

Full description

Bibliographic Details
Main Authors: Ivo Noci, Flavia Sorbi, Luca Mannini, Elisabetta Projetto, Serena Pillozzi, Viola Ghizzoni, Tiziano Lottini, Daniela Moncini, Gianna Baroni, Francesco Mungai, Annarosa Arcangeli, Massimiliano Fambrini
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-08-01
Series:Frontiers in Oncology
Subjects:
Recurrence
biomarker
endometrial cancer
molecular analysis
Immunohistochemical analysis
LH/hCG receptor
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00190/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00190/full

Similar Items